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SUMMARY : Postoperative coagulation changes were studied in 50 patients with 
esophageal carcinomas for 7 days following operation. Of these, 12 patients were examined 
further for changes in platelet aggregation rate as an index of platelet function. Just 
after operation, both platelet count and aggregation rate decreased, but at day 2 when 
the platelet count reached its lowest point, platelet aggregation returned to the preoperative 
level. Altough platelet aggregation decreased again, it recovered to the preoperative level 
earlier than did the platelet count. Changes in prothrombin time, activated partial 
thromboplastin time and fibrinogen and FDP-E levels may suggest pre-DIC state.
       INTRODUCTION 
 There have been numerous reports on 
changes in the coagulation and fibrinolytic 
system in patients before and after operation. 
However, little has been reported regarding 
changes in platelet function, coagulation, and 
the fibrinolytic system after massive blood 
transfusions for major surgeries such as sur-
gery for esophageal carcinoma. Therefore, we 
investigated changes of these factors in pre-
operative and postoperative days. 
   SUBJECTS AND METHODS 
 The subjects for this study were 50 patients 
who underwent esophagectomy and or esopha-
geal reconstruction for esophageal carcinoma, 
and had not received anticoagulants. Of these, 
12 patients were assessed for changes in the 
maximum platelet aggregation rate. During op-
eration a crystalloid solution was administer-
ed as transfusion fluid at the rate of 10ml. 
kg/hr, and preserved whole blood was trans-
fused to supplement blood loss by bleeding. 
Furthermore, fresh frozen plasma was trans-
fused to maintain circulating blood volume. 
Platelet transfusions were not performed during 
or after operation. Postoperatively, the patients 
were transfused with fresh frozen plasma for 
up to 7 days to maintain serum albumine and 
coagulation factors. Within 3 hours after blood 
samples were obtained, the maximum platelet 
aggregation rate was determined in the presence 
of ADP at a final concectration of 3,uM or in 
the presence of collagen at 2,ug/ml, using a 
HEMA TRACER PAC-8S (Niko Bioscience Co., 
Ltd.). The platelet count was determined with 
an automatic blood counting cytometer MEK 
7108 (Nihon Koden Co., Ltd.). The prothrombin 
time (PT), the activated partial thromboplastin 
time (APTT), and the fibrinogen level were all 
mesasured with a coagustat Auto II (Interna-
tional Reagent Co., Ltd.). FDP-E was meas-
ured with a diayatron LPIA system. Measure-
ments were performed before operation (control 
values) and for postoperative 7 days. The data 
were statistically analyzed using an unpaired 
t-test, and statistical differences were consid-
ered significant for p<0.05. All values were 
expressed as means ± SE.
 The maximum platelet aggregation rate began 
to decline after operation, and reached 67.0±4.0% 
at day 1. This represented a significant decrease 
from the preoperative value of 91.4±2.6%. At
          RESULTS 
1) Changes in platelet count (Fig. 1) 
 Mean blood loss was 1,150g during operation. 
After operation, platelet count decreased sig-
nificantly from 24.1±1.4 x 109/mm3 (control) to 
10.6±0.7 x 104 /mm' at day 2 after operatrion. 
Thereafter, the platelet count increased grad-
ually, recovering to the preoperative level by day 
7.
2) Changes in the maximum platelet aggrega-
tion rate in the presence of ADP.
Fig. 2. Changes in the maximum platelet aggrega-
      tion rate in the presence of ADP. Each point 
       represents mean ± SE.
Fig. 1. Changes in platelet count after surgery 
      Each point represents mean ± SE.
Fig. 3. Changes in the maximum platelet aggrega-
       tion rate in the presence of collagen. Each 
       point represents mean ± SE.
Table 1. Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen and FDP 
         changes after operation.
          Pre 1POD 2POD 3POD 4POD 5POD 6POD 7POD 
  PT * 
  (%) 100.9± 2.4 83.2± 2.4 99.2± 7.4 118.8± 12.3 104.4± 9.5 88.8±10.3 96.3±21.6 92.5±10.8 
 APTT * * ** *** 
  (%) 109.0± 2.1 80.0± 1.9 74.1± 3.9 78.9± 4.6 79.0± 3.2 82.4±4.3 86.8± 3.6 92.1± 1.6 
Fibrinogen * * * * ** ** * 
 (mg/dl) 415.0±20.0 468.2±12.3 545.4±26.9 586.2± 32.1 550.1±24.6 584.5±81.1 564.4± 65.9 648.7±35.1 
 FDP * ** * * * * 
 (ng/ml) 48.5± 8.4 409.8±47.3 237.5±39.1 409.3±110.2 491.0±62.3 738.2±75.0 658.4±110.4 617.3±87.5 
      VS. pre *P<0.001 **P<0.01 ***P<0.05 All data are presented as mean±SE.
day 2, when the platelet count reached minimum 
level, the aggregation rate tempolarily rose to 
82.4±4.4%, but fell again to 71.9±4.8% at day 3. 
Thereafter, this rate rose to 82.7±6.1%, equiv-
alent to control level at day 6, which is ealier 
than recovery of the platelet count. 
3) Changes in the maximum platelet aggrega-
tion rate in the presence of collagen (Fig. 3). 
 An aggregating agent, ADP, mainly indi-
cates changes in primary platelet aggregation, 
whereas collgen detects secondary platelet ag-
gregation in response to intrinsic ADP release. 
Changes in the collagen induced maximum 
platelet aggregation rate show similar tendency 
to those induced by ADP. Namely, the aggrega-
tion rate decreased significantly from 85.1±2.9% 
(control level) to 57.9±6.0% at day 1. At day 
2, when the platelet count fell to minimum level, 
the aggregation rate rose temporarily to the 
preoperative level, and fell again. As with ADP, 
it recovered to the control level by day 6. 
4) Changes in prothrombin time (Table 1). 
 After operation, prothrombin time decreased 
significantly from 100.9±2.4% (control) to 83.2± 
2.4% at day 1 and returned to the preoperative 
value at day 2. 
5) Changes in the partial thromboplastin time 
(Table 1). 
 After operation, partial thromboplastin time 
(PTT) decreased significantly from 109.0±2.1% 
(control) to 74.1±3.9% at day 2. Although this 
PTT increased gradually thereafter, it remained 
significantly lower than the preoperative level 
even at day 7. 
6) Changes in fibrinogen level (Table 1). 
 Fibrinogen level was already high (415.6± 
20.0mg/dl) before operation because of the 
malignant disease. After operation, fibrinogen 
level rose further to 545.4±26.9mg/dl at day 2, 
significant difference from the preoperative 
level. This elevation persisted up to day 7. 
7) Changes in the EDP-E level (Table 1). 
 After operation, FDP-E level was significantly 
elevated from 48.5±8.4ng/ml (control) to 409.9± 
47.3ng/ml at day 2. This elevation persisted up
to day 7.
         DISCUSSION 
 Major surgeries, such as curative surgery for 
esophangeal carcinoma, involve extensive areas., 
of invasion and massive bleeding, and require 
large blood transfusions. This is believed to 
produce a preliminary DIC state, such as 
decrease in coagulation factors and activation 
of the coagulation and fibrinolytic system by 
release of tissue thromboplastin". This study 
was designed to clarify the changes in platelet 
count, aggregation, and the coagulation and 
fibrinolytic system of patients with surgically 
treated esophageal carcinomas during the first 
week after surgery. 
 Postoperatively platelet count decreased 
significantly to about 40% of the preoperative 
level at day 2. This was due to blood dilution 
resulting from massive bleeding and blood 
transfusions during surgery. Thereafter, plate-
let count increased gradually, recovering to the 
preoperative level by day 7. 
 Reactive thrombocytosis is usually known to 
develop after operation. It is due to increased 
platelet production resulting from stimulation 
of bone marrow by bleeding and blood trans-
fusion. However, this phenomenon was not 
observed in our patients throughout the 7 days 
observed period, probably because platelet com-
sumption increased during and after opera-
tion due to extensive surgical invasion and 
massive bleeding. Reactive thrombocytosis is 
likely to occur about two weeks after operation, 
Although the data were not stastistically ana-
lyzed, there were some cases with increased 
platelet counts around that time in our study. 
Platelets play various roles in coagulation and 
the fibrinolytic system, including establishment 
of hemostasis by forming a thrombus, activation 
of coagulation factors, supporting the capillary 
endothelium, and storing carring materials'1' 12) 
For those reasons, besides platelet count, platelet 
aggregation, reflecting the platelet function, was 
also determined to evaluate various pathologi-
cal states such as myocardial infarction, cere-
brovascular impairment, and diseases requir-
ing hemodialysis' . And the effects of anesthet-
2 ics on platelet function were also studied' 4. ' ' 9,
In this study, we assessed changes in platelet 
aggregation rate concurrent with changes in 
platelet count for up to 7 days following opera-
tion. After operation, platelet aggregation rate 
decreased significantly, as did platelet count. 
However, at day 2, when platelet count was 
depressed to low level, aggregation rate 
temporarily rose to preoperative level as if to 
compensate for the depression of platelet 
counts. Although it again decreased, aggrega-
tion rate returned to the preoperative level at 
day 6, one day ealier than recovery of the platelet 
count. From the result at day 2, it is suggested 
that in spite of decreased platelet count, the 
tendency to bleed was inhibited by temporary 
restoration of platelet function. However, DIC 
is a unique pathological state in which activa-
tion of the intravascular coagulation and plate-
let systems produces multiple thrombosis, there-
by depleting coagulation factors and platelets. 
These results in a tendency to bleed. Therefore, 
paradoxically speaking, it is possible that activa-
tion of the platelet function at day 2 contributed 
to the acceleration of DIC. Our study clearly 
indicates that recovery of platelet aggregation 
rate is faster than recovery of platelet count, 
though only by one day. According to a study 
that measured the speed of recovery of plate-
lets and coagulation factors reduced by DIC, 
recovery of factor VIII and fibrinogen was faster 
than recovery of platelets. However, we believe 
that restoration of platelet function precedes 
recovery of the platelet count, as seen in our 
study. Therefore, we must be careful in deciding 
platelet transfusion based solely on a decrease 
in platelet count"'. In fact, it has been reported 
that administration of desmopressin acetate 
helped restore platelet function reduced by 
extracorporeal circulation during cardiac sur-
gery, thereby reducing bleeding'. Therefore, if 
recovery of sufficient platelet count is not 
observed within two days following surgery in 
spite of a lack of bleeding, it is necessary to 
measure platelet function and take caution in 
the development of DIC. A blood vessel 
ruptured by surgical invasion causes blood to 
come into contact with the rough surface. This 
activates factor XII, which leads to activation 
of the intrinsic coagulaton mechanism. Surgical 
invasion also causes intravascular influx of
tissue thromboplastin and thromboplastin-like 
substances, triggering activation of the extrinsic 
coagulation machanism. After operation, both 
PT and APTT decreased significantly in our 
patients. PT recovered at day 2, whereas APTT 
remained low level even at day 7. Normal level 
of PT and prolonged low level of APTT suggest 
deficiency or absence of factors XII, XI, IX, and 
VIII. Since our patients were transfused with 
sufficient amounts of fresh frozen plasma to 
supplement serum albumin, deficiencies of these 
factors are unlikely. Decreases in the half-lives 
of these factors, the presence of catheter in the 
blood vessel, or depletion of platelet factor III 
due to decreased platelet function may explain 
the prolonged low APTT levels in our patients"). 
In anyway, further study is necessary to clarify 
this question. It appears that the decreases in 
coagulation factors in our patients were not 
great enough to induce bleeding'). After sur-
gery, both fibrinogen and FDP-E levels were 
significantly elevated and remained high even 
at day 7. Fibrinogen is one of proteins produced 
by acute reactions, and its elevation in our 
patients seems to have been caused by surgical 
invasion. FDP-E, a degradation product of 
fibrinogen, was probably elevated for the some 
reasen. Therefore, elevation of fibrinogen levels 
is common after surgery. We must be aware 
that even if fibrinogen is not decreased, the 
possibility of DIC cannot be ruled out. 
 We have discussed changes in coagulation, 
fibrinolysis, and platelet systems of patiens with 
esophageal carcinoma after surgery. Although 
there are many methods for determing coagu-
lability5, "' we believe that evaluation of plate-
let function is important, because it plays a 
major role in pastoperative bleeding.
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